TI
Tibbiyah Stock: price and insider trades · Saudi Arabia
Tibbiyah: what insiders have been doing
Insider filings for Tibbiyah are scarce in the Tadawul (CMA) feed, the latest one published on 26 January 2026. This page will fill in as new trades are disclosed. Source: insider filings from Tadawul (CMA). Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 14,354 of 26,897 companies
49.6
score / 100
Value59
Quality41
FCF yld-0.6%
Earn yld6.3%
EV/EBITDA7.9x
ROE9.0%
Gross mgn23%
Net mgn2.8%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SAR 18.79
Analyst consensus
Income statement
RevenueSAR 842.2M
Gross profitSAR 194.8M23% margin
EBITDASAR 89.9M11% margin
Net incomeSAR 23.6M3.5% margin
Valuation
PER (trailing)10.9x
P/Book1.1x
Beta0.20
Balance sheet & cash
Market capSAR 375.8M
Total debtSAR 336.9M
Free Cash Flow-SAR 2.1M
Debt / Equity112%
Profitability & ownership
ROE9.0%
ROA3.8%
% institutions0.0%
Last declaration on 26 January 2026
Declarations7 total
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
- ●Executives0Tadawul
7 of 7 declarations
About Tibbiyah
Tibbiyah is a company operating in the healthcare and pharmaceutical sector. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations